Ultrastructural Analysis of ICP34.5− Herpes Simplex Virus 1 Replication in Mouse Brain Cells In Vivo
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...
Saved in:
Published in | Journal of Virology Vol. 84; no. 21; pp. 10982 - 10990 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.11.2010
American Society for Microbiology (ASM) |
Subjects | |
Online Access | Get full text |
ISSN | 0022-538X 1098-5514 1098-5514 |
DOI | 10.1128/JVI.00337-10 |
Cover
Loading…
Abstract | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
---|---|
AbstractList | Replication-competent forms of herpes simplex virus 1 (HSV-1) defective in the viral neurovirulence factor infected cell protein 34.5 (ICP34.5) are under investigation for use in the therapeutic treatment of cancer. In mouse models, intratumoral injection of ICP34.5-defective oncolytic HSVs (oHSVs) has resulted in the infection and lysis of tumor cells, an associated decrease in tumor size, and increased survival times. The ability of these oHSVs to infect and lyse cells is frequently characterized as exclusive to or selective for tumor cells. However, the extent to which ICP34.5-deficient HSV-1 replicates in and may be neurotoxic to normal brain cell types
in vivo
is poorly understood. Here we report that HSV-1 defective in ICP34.5 expression is capable of establishing a productive infection in at least one normal mouse brain cell type. We show that γ
34.5
deletion viruses replicate productively in and induce cellular damage in infected ependymal cells. Further evaluation of the effects of oHSVs on normal brain cells in animal models is needed to enhance our understanding of the risks associated with the use of current and future oHSVs in the brains of clinical trial subjects and to provide information that can be used to create improved oHSVs for future use. Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI Replication-competent forms of herpes simplex virus 1 (HSV-1) defective in the viral neurovirulence factor infected cell protein 34.5 (ICP34.5) are under investigation for use in the therapeutic treatment of cancer. In mouse models, intratumoral injection of ICP34.5-defective oncolytic HSVs (oHSVs) has resulted in the infection and lysis of tumor cells, an associated decrease in tumor size, and increased survival times. The ability of these oHSVs to infect and lyse cells is frequently characterized as exclusive to or selective for tumor cells. However, the extent to which ICP34.5-deficient HSV-1 replicates in and may be neurotoxic to normal brain cell types in vivo is poorly understood. Here we report that HSV-1 defective in ICP34.5 expression is capable of establishing a productive infection in at least one normal mouse brain cell type. We show that γ34.5 deletion viruses replicate productively in and induce cellular damage in infected ependymal cells. Further evaluation of the effects of oHSVs on normal brain cells in animal models is needed to enhance our understanding of the risks associated with the use of current and future oHSVs in the brains of clinical trial subjects and to provide information that can be used to create improved oHSVs for future use.Replication-competent forms of herpes simplex virus 1 (HSV-1) defective in the viral neurovirulence factor infected cell protein 34.5 (ICP34.5) are under investigation for use in the therapeutic treatment of cancer. In mouse models, intratumoral injection of ICP34.5-defective oncolytic HSVs (oHSVs) has resulted in the infection and lysis of tumor cells, an associated decrease in tumor size, and increased survival times. The ability of these oHSVs to infect and lyse cells is frequently characterized as exclusive to or selective for tumor cells. However, the extent to which ICP34.5-deficient HSV-1 replicates in and may be neurotoxic to normal brain cell types in vivo is poorly understood. Here we report that HSV-1 defective in ICP34.5 expression is capable of establishing a productive infection in at least one normal mouse brain cell type. We show that γ34.5 deletion viruses replicate productively in and induce cellular damage in infected ependymal cells. Further evaluation of the effects of oHSVs on normal brain cells in animal models is needed to enhance our understanding of the risks associated with the use of current and future oHSVs in the brains of clinical trial subjects and to provide information that can be used to create improved oHSVs for future use. Replication-competent forms of herpes simplex virus 1 (HSV-1) defective in the viral neurovirulence factor infected cell protein 34.5 (ICP34.5) are under investigation for use in the therapeutic treatment of cancer. In mouse models, intratumoral injection of ICP34.5-defective oncolytic HSVs (oHSVs) has resulted in the infection and lysis of tumor cells, an associated decrease in tumor size, and increased survival times. The ability of these oHSVs to infect and lyse cells is frequently characterized as exclusive to or selective for tumor cells. However, the extent to which ICP34.5-deficient HSV-1 replicates in and may be neurotoxic to normal brain cell types in vivo is poorly understood. Here we report that HSV-1 defective in ICP34.5 expression is capable of establishing a productive infection in at least one normal mouse brain cell type. We show that 34.5 deletion viruses replicate productively in and induce cellular damage in infected ependymal cells. Further evaluation of the effects of oHSVs on normal brain cells in animal models is needed to enhance our understanding of the risks associated with the use of current and future oHSVs in the brains of clinical trial subjects and to provide information that can be used to create improved oHSVs for future use. Replication-competent forms of herpes simplex virus 1 (HSV-1) defective in the viral neurovirulence factor infected cell protein 34.5 (ICP34.5) are under investigation for use in the therapeutic treatment of cancer. In mouse models, intratumoral injection of ICP34.5-defective oncolytic HSVs (oHSVs) has resulted in the infection and lysis of tumor cells, an associated decrease in tumor size, and increased survival times. The ability of these oHSVs to infect and lyse cells is frequently characterized as exclusive to or selective for tumor cells. However, the extent to which ICP34.5-deficient HSV-1 replicates in and may be neurotoxic to normal brain cell types in vivo is poorly understood. Here we report that HSV-1 defective in ICP34.5 expression is capable of establishing a productive infection in at least one normal mouse brain cell type. We show that γ34.5 deletion viruses replicate productively in and induce cellular damage in infected ependymal cells. Further evaluation of the effects of oHSVs on normal brain cells in animal models is needed to enhance our understanding of the risks associated with the use of current and future oHSVs in the brains of clinical trial subjects and to provide information that can be used to create improved oHSVs for future use. |
Author | Jacqueline Muller Nancy S. Markovitz Hina Mehta |
AuthorAffiliation | Division of Cellular and Gene Therapies, 1 Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 2 |
AuthorAffiliation_xml | – name: Division of Cellular and Gene Therapies, 1 Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 2 |
Author_xml | – sequence: 1 givenname: Hina surname: Mehta fullname: Mehta, Hina organization: Division of Cellular and Gene Therapies – sequence: 2 givenname: Jacqueline surname: Muller fullname: Muller, Jacqueline organization: Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland – sequence: 3 givenname: Nancy S. surname: Markovitz fullname: Markovitz, Nancy S. organization: Division of Cellular and Gene Therapies |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23320899$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20702618$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1u1DAUhS1URKeFHWtkCSE2ZLj-S5xNpTIqdFARCGjFzvJ4nI4rxwl2MqVvwJpH5ElwO0P5kRArW_Z3j87RPXtoJ3TBIvSQwJQQKp-_PptPARirCgJ30IRALQshCN9BEwBKC8Hkp120l9IFAOG85PfQLoUKaEnkBDWnfog6DXE0wxi1x4dB-6vkEu4aPJ-9Y3wqvn_9ho9t7G3CH1zbe_sFn7k4Jkzwe9t7Z_TguoBdwG-6MVn8Iup8n1nvE56HzK67--huo32yD7bnPjp9efRxdlycvH01nx2eFIZXbChKYyQsyJITkABlCbwEQjWRomHGmrqSjTRgtNGMEymNldqIpdSMLEohqWH76GCj24-L1i6NDTmdV310rY5XqtNO_fkT3Eqdd2tFa8Eo8CzwdCsQu8-jTYNqXTI5ig42h1NVSWlFBRf_J0VFqqqmJJOPfjd16-bnFjLwZAvoZLRvog7GpV8cy9ZkXWfu2YYzsUsp2uYWIaCuy6ByGdRNGfJLxulfuHHDza5ydOf_NfR4M7Ry56tLF63SqVUXa6ckV5So635R9gMfO8I4 |
CitedBy_id | crossref_primary_10_1002_jmv_25691 crossref_primary_10_1038_cgt_2011_34 crossref_primary_10_1186_s12974_024_03240_2 crossref_primary_10_1128_JVI_01156_17 crossref_primary_10_1016_j_omto_2017_02_001 crossref_primary_10_3390_cancers3010368 |
Cites_doi | 10.1099/0022-1317-75-12-3679 10.1099/0022-1317-79-3-525 10.1002/glia.440140102 10.1128/JVI.79.20.13047-13059.2005 10.1038/nm0995-938 10.1007/BF01718314 10.1073/pnas.012485299 10.1016/j.bbr.2005.05.002 10.1128/JVI.74.8.3832-3841.2000 10.1128/JVI.78.14.7653-7666.2004 10.1128/JVI.80.3.1610-1612.2006 10.1007/BF00301080 10.1007/s12250-008-3004-1 10.1128/JVI.00386-06 10.1016/j.brainresrev.2004.12.012 10.1016/0092-8674(81)90247-6 10.1016/j.neuroscience.2008.06.065 10.1128/JVI.72.12.9992-10002.1998 10.1128/jvi.71.7.5560-5569.1997 10.1586/14737175.7.4.321 10.1016/j.chom.2006.12.001 10.1099/0022-1317-72-3-631 10.1128/JVI.73.10.8010-8018.1999 10.1172/JCI116527 10.1016/j.ymthe.2006.02.006 10.1016/0042-6822(89)90244-4 10.1038/sj.cgt.7700946 10.1016/0092-8674(81)90346-9 10.4161/hv.4.2.6212 10.1089/hum.1997.8.17-2057 10.1099/0022-1317-2-3-357 10.1016/S0092-8674(00)80956-3 10.1126/science.2173860 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS Copyright © 2010, American Society for Microbiology 2010 |
Copyright_xml | – notice: 2015 INIST-CNRS – notice: Copyright © 2010, American Society for Microbiology 2010 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7TK 7U9 H94 5PM |
DOI | 10.1128/JVI.00337-10 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Neurosciences Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Neurosciences Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
EndPage | 10990 |
ExternalDocumentID | PMC2953204 20702618 23320899 10_1128_JVI_00337_10 jvi_84_21_10982 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Journal Article |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ AAYXX ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 D0S DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM IQODW CGR CUY CVF ECM EIF NPM 7X8 7TK 7U9 H94 5PM |
ID | FETCH-LOGICAL-c473t-6cc80b1d41080066046012a185f3cec978f8c0caca34188ce8ac5d8a31b6582c3 |
ISSN | 0022-538X 1098-5514 |
IngestDate | Thu Aug 21 17:56:17 EDT 2025 Fri Sep 05 03:18:24 EDT 2025 Fri Sep 05 06:59:52 EDT 2025 Mon Jul 21 06:01:46 EDT 2025 Mon Jul 21 09:15:46 EDT 2025 Tue Jul 01 00:57:46 EDT 2025 Thu Apr 24 23:03:10 EDT 2025 Wed May 18 15:25:59 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 21 |
Keywords | Virus Vertebrata Mammalia Mouse Herpesviridae Alphaherpesvirinae Rodentia Human herpesvirus 1 Replication Encephalon |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c473t-6cc80b1d41080066046012a185f3cec978f8c0caca34188ce8ac5d8a31b6582c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/2953204 |
PMID | 20702618 |
PQID | 757177921 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmed_primary_20702618 proquest_miscellaneous_757177921 pascalfrancis_primary_23320899 crossref_primary_10_1128_JVI_00337_10 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2953204 proquest_miscellaneous_762272545 highwire_asm_jvi_84_21_10982 crossref_citationtrail_10_1128_JVI_00337_10 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-11-01 |
PublicationDateYYYYMMDD | 2010-11-01 |
PublicationDate_xml | – month: 11 year: 2010 text: 2010-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Journal of Virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2010 |
Publisher | American Society for Microbiology American Society for Microbiology (ASM) |
Publisher_xml | – name: American Society for Microbiology – name: American Society for Microbiology (ASM) |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 (e_1_3_2_30_2) 2007 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_14_2 e_1_3_2_35_2 (e_1_3_2_2_2) 1997; 57 15220440 - J Virol. 2004 Jul;78(14):7653-66 11756670 - Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):190-5 7585221 - Nat Med. 1995 Sep;1(9):938-43 10729157 - J Virol. 2000 Apr;74(8):3832-41 9188630 - J Virol. 1997 Jul;71(7):5560-9 9519831 - J Gen Virol. 1998 Mar;79 ( Pt 3):525-36 9811737 - J Virol. 1998 Dec;72(12):9992-10002 16574492 - Mol Ther. 2006 May;13(5):891-8 8044808 - Childs Nerv Syst. 1994 Apr;10(3):151-5 6268303 - Cell. 1981 Jul;25(1):227-32 18496918 - Hum Vaccin. 2008 Mar-Apr;4(2):91-105 6263501 - Cell. 1981 May;24(2):555-65 9414254 - Hum Gene Ther. 1997 Nov 20;8(17):2057-68 16604059 - Cancer Gene Ther. 2006 Nov;13(11):975-92 10482549 - J Virol. 1999 Oct;73(10):8010-8 9989494 - Cell. 1999 Jan 8;96(1):25-34 4300104 - J Gen Virol. 1968 May;2(3):357-64 9108452 - Cancer Res. 1997 Apr 15;57(8):1502-9 8390490 - J Clin Invest. 1993 Jun;91(6):2837-43 16415038 - J Virol. 2006 Feb;80(3):1610-1; author reply 1611-2 8645092 - Arch Virol. 1996;141(3-4):505-24 17425484 - Expert Rev Neurother. 2007 Apr;7(4):321-4 7996163 - J Gen Virol. 1994 Dec;75 ( Pt 12):3679-86 2173860 - Science. 1990 Nov 30;250(4985):1262-6 2554573 - Virology. 1989 Nov;173(1):276-83 15990178 - Behav Brain Res. 2005 Sep 8;163(2):227-36 1848598 - J Gen Virol. 1991 Mar;72 ( Pt 3):631-9 15850661 - Brain Res Brain Res Rev. 2005 Apr;48(2):220-33 18682279 - Neuroscience. 2008 Sep 22;156(1):81-8 18005679 - Cell Host Microbe. 2007 Mar 15;1(1):23-35 7615341 - Glia. 1995 May;14(1):1-13 16189007 - J Virol. 2005 Oct;79(20):13047-59 16775362 - J Virol. 2006 Jul;80(13):6716-7; author replies 6717-9 |
References_xml | – ident: e_1_3_2_3_2 doi: 10.1099/0022-1317-75-12-3679 – ident: e_1_3_2_17_2 doi: 10.1099/0022-1317-79-3-525 – ident: e_1_3_2_8_2 doi: 10.1002/glia.440140102 – ident: e_1_3_2_19_2 doi: 10.1128/JVI.79.20.13047-13059.2005 – ident: e_1_3_2_26_2 doi: 10.1038/nm0995-938 – ident: e_1_3_2_34_2 doi: 10.1007/BF01718314 – ident: e_1_3_2_36_2 doi: 10.1073/pnas.012485299 – start-page: 2501 year: 2007 ident: e_1_3_2_30_2 publication-title: Fields virology – ident: e_1_3_2_11_2 – ident: e_1_3_2_24_2 doi: 10.1016/j.bbr.2005.05.002 – ident: e_1_3_2_35_2 doi: 10.1128/JVI.74.8.3832-3841.2000 – ident: e_1_3_2_15_2 doi: 10.1128/JVI.78.14.7653-7666.2004 – ident: e_1_3_2_25_2 doi: 10.1128/JVI.80.3.1610-1612.2006 – ident: e_1_3_2_32_2 doi: 10.1007/BF00301080 – ident: e_1_3_2_31_2 doi: 10.1007/s12250-008-3004-1 – ident: e_1_3_2_4_2 doi: 10.1128/JVI.00386-06 – ident: e_1_3_2_13_2 doi: 10.1016/j.brainresrev.2004.12.012 – ident: e_1_3_2_29_2 doi: 10.1016/0092-8674(81)90247-6 – ident: e_1_3_2_12_2 doi: 10.1016/j.neuroscience.2008.06.065 – ident: e_1_3_2_6_2 doi: 10.1128/JVI.72.12.9992-10002.1998 – ident: e_1_3_2_22_2 doi: 10.1128/jvi.71.7.5560-5569.1997 – ident: e_1_3_2_10_2 doi: 10.1586/14737175.7.4.321 – ident: e_1_3_2_27_2 doi: 10.1016/j.chom.2006.12.001 – ident: e_1_3_2_20_2 doi: 10.1099/0022-1317-72-3-631 – ident: e_1_3_2_23_2 doi: 10.1128/JVI.73.10.8010-8018.1999 – ident: e_1_3_2_37_2 doi: 10.1172/JCI116527 – volume: 57 start-page: 1502 year: 1997 ident: e_1_3_2_2_2 publication-title: Cancer Res. – ident: e_1_3_2_7_2 doi: 10.1016/j.ymthe.2006.02.006 – ident: e_1_3_2_14_2 doi: 10.1016/0042-6822(89)90244-4 – ident: e_1_3_2_33_2 doi: 10.1038/sj.cgt.7700946 – ident: e_1_3_2_28_2 doi: 10.1016/0092-8674(81)90346-9 – ident: e_1_3_2_21_2 doi: 10.4161/hv.4.2.6212 – ident: e_1_3_2_18_2 doi: 10.1089/hum.1997.8.17-2057 – ident: e_1_3_2_9_2 doi: 10.1099/0022-1317-2-3-357 – ident: e_1_3_2_16_2 doi: 10.1016/S0092-8674(00)80956-3 – ident: e_1_3_2_5_2 doi: 10.1126/science.2173860 – reference: 4300104 - J Gen Virol. 1968 May;2(3):357-64 – reference: 15220440 - J Virol. 2004 Jul;78(14):7653-66 – reference: 9108452 - Cancer Res. 1997 Apr 15;57(8):1502-9 – reference: 9989494 - Cell. 1999 Jan 8;96(1):25-34 – reference: 16775362 - J Virol. 2006 Jul;80(13):6716-7; author replies 6717-9 – reference: 6268303 - Cell. 1981 Jul;25(1):227-32 – reference: 16189007 - J Virol. 2005 Oct;79(20):13047-59 – reference: 18682279 - Neuroscience. 2008 Sep 22;156(1):81-8 – reference: 17425484 - Expert Rev Neurother. 2007 Apr;7(4):321-4 – reference: 7996163 - J Gen Virol. 1994 Dec;75 ( Pt 12):3679-86 – reference: 7615341 - Glia. 1995 May;14(1):1-13 – reference: 18496918 - Hum Vaccin. 2008 Mar-Apr;4(2):91-105 – reference: 6263501 - Cell. 1981 May;24(2):555-65 – reference: 9811737 - J Virol. 1998 Dec;72(12):9992-10002 – reference: 2173860 - Science. 1990 Nov 30;250(4985):1262-6 – reference: 16574492 - Mol Ther. 2006 May;13(5):891-8 – reference: 9414254 - Hum Gene Ther. 1997 Nov 20;8(17):2057-68 – reference: 18005679 - Cell Host Microbe. 2007 Mar 15;1(1):23-35 – reference: 16604059 - Cancer Gene Ther. 2006 Nov;13(11):975-92 – reference: 10482549 - J Virol. 1999 Oct;73(10):8010-8 – reference: 8390490 - J Clin Invest. 1993 Jun;91(6):2837-43 – reference: 1848598 - J Gen Virol. 1991 Mar;72 ( Pt 3):631-9 – reference: 2554573 - Virology. 1989 Nov;173(1):276-83 – reference: 10729157 - J Virol. 2000 Apr;74(8):3832-41 – reference: 15850661 - Brain Res Brain Res Rev. 2005 Apr;48(2):220-33 – reference: 9188630 - J Virol. 1997 Jul;71(7):5560-9 – reference: 8044808 - Childs Nerv Syst. 1994 Apr;10(3):151-5 – reference: 16415038 - J Virol. 2006 Feb;80(3):1610-1; author reply 1611-2 – reference: 7585221 - Nat Med. 1995 Sep;1(9):938-43 – reference: 8645092 - Arch Virol. 1996;141(3-4):505-24 – reference: 9519831 - J Gen Virol. 1998 Mar;79 ( Pt 3):525-36 – reference: 11756670 - Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):190-5 – reference: 15990178 - Behav Brain Res. 2005 Sep 8;163(2):227-36 |
SSID | ssj0014464 |
Score | 2.0288153 |
Snippet | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... Replication-competent forms of herpes simplex virus 1 (HSV-1) defective in the viral neurovirulence factor infected cell protein 34.5 (ICP34.5) are under... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 10982 |
SubjectTerms | Animals Biological and medical sciences Brain - pathology Brain - virology Defective Viruses - pathogenicity Defective Viruses - ultrastructure Fundamental and applied biological sciences. Psychology Gene Deletion Herpes Simplex Herpes simplex virus 1 Herpesvirus 1, Human - genetics Herpesvirus 1, Human - pathogenicity Mice Microbiology Miscellaneous Oncolytic Virotherapy Oncolytic Viruses - genetics Viral Proteins - genetics Virology Virus Replication Virus-Cell Interactions |
Title | Ultrastructural Analysis of ICP34.5− Herpes Simplex Virus 1 Replication in Mouse Brain Cells In Vivo |
URI | http://jvi.asm.org/content/84/21/10982.abstract https://www.ncbi.nlm.nih.gov/pubmed/20702618 https://www.proquest.com/docview/757177921 https://www.proquest.com/docview/762272545 https://pubmed.ncbi.nlm.nih.gov/PMC2953204 |
Volume | 84 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZgERIXxJvAsvIBTlFK7SS1c0QrULfSIg5b1FvkuI42qJtWbYmAX8-M7aTpqkXAJaoc15HyfZ7MjOdByNuhkrFWiYmkhE2eAMogB7WKCh0XstTDNC0xOfny82g8TSazdLZrl2qzS7bFQP86mFfyP6jCGOCKWbL_gGy3KAzAb8AXroAwXP8K4-liu1auAqytnqF6FUYuzr_EySCNQBVcr8wm3FRYB_hH2FTr75uQ4WFB669Dnwd6AExYYMOIEJ35Nky2qZrlEe0V0-P6DvlLc-300LHvx-1QbBMNJ0rDB2jRO8THJKFlU9l2sk7Gey-sd0FgOEfngjBObGJVUtS9-nLVtX7z_HFp0F5K4nR-WH5zzEmYfL0YYJM5EbmQ1x6UqxuLJQdJBbaf3H3FutjC9tZdco-D6WDbecy6sB80f5M2AYLL9_1HYWFo_-d9LaWtHI2Bs2oDe6d0TU8OWSW3g2t72srVI_LQA0U_OM48JndM_YTcd41Hfz4l81vMoS1z6LKkLXOoYw71zKGWOZTRHnNoVVPLHGqZQy1zcBCZ84xMP328Oh9Hvt9GpBMRb6OR1nJYsHmCcaegiuKZOeMKNLoy1kZnQpZSw0bWClQfKbWRSqdzqWJWgB7LdfycnNTL2rwkNC14CdOFGZosYfNhphjopizT80KNEjEKSNi-31z7YvTYE2WRW6OUyxyAyS0wMBKQd93slSvCcmTeaQtVrjY3-bemymWSc5ZbxgXkbA--bi0exxyPvwNCWzxzkLL4zlRt4C3mIhVMiIyzP0wZcS44GCQBeeEYsFvfsyogYo8b3QSs8b5_p66uba13nmHnluTV0TVfkwe7LXlKToA55g3oydvizBL_N6oTvds |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ultrastructural+analysis+of+ICP34.5-+herpes+simplex+virus+1+replication+in+mouse+brain+cells+in+vivo&rft.jtitle=Journal+of+virology&rft.au=Mehta%2C+Hina&rft.au=Muller%2C+Jacqueline&rft.au=Markovitz%2C+Nancy+S&rft.date=2010-11-01&rft.eissn=1098-5514&rft.volume=84&rft.issue=21&rft.spage=10982&rft_id=info:doi/10.1128%2FJVI.00337-10&rft_id=info%3Apmid%2F20702618&rft.externalDocID=20702618 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |